|
|
Blood, 15 December 2005, Vol. 106, No. 13, pp. 4234-4240.
Prepublished online as a Blood First Edition Paper on August 30, 2005; DOI 10.1182/blood-2005-05-1871.
Previous Article | Next Article 
Submitted May 9, 2005
Accepted August 13, 2005
TGF- type II receptor deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo
Per Leveen, Maria Carlsen, Anna White-Makowska, Saemundur Oddsson, Jonas Larsson, Marie-Jose Goumans, Corrado M Cilio*, and Stefan Karlsson
Molecular Medicine and Gene Therapy, Institute of Laboratory Medicine and The Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
Dept. of Clinical Sciences, Cellular Autoimmunity Unit,, Malmo University Hospital, Lund University, Malmo, Sweden
Netherlands Cancer Institute, Amsterdam, The Netherlands
* Corresponding author; email: corrado.cilio{at}med.lu.se.
We have taken advantage of the Cre/lox system to generate a mouse model with inducible deficiency of transforming growth factor receptor II (T RII). Using this approach, transforming growth factor (TGF- ) signaling deficiency can be restricted to the hematopoietic system by bone marrow transplantation. Mice transplanted with T RII -/- bone marrow develop a lethal inflammatory disorder closely resembling that of TGF- 1 null mice. Previous in vitro studies have suggested multiple roles for TGF- in T cell development, including proliferation, apoptosis and differentiation. We used our transplantation model to ask whether T cell development is normal in the absence of TGF- signaling. The findings show for the first time in vivo and in foetal thymus organ culture (FTOC) that TGF- is not required for thymocytes to differentiate along the entire pathway of thymic T cell development, as defined by the expression patterns of CD4, CD8, CD25 and CD44. In contrast to previous investigations, no increase of thymocyte apoptosis was observed. However, T RII deficient CD8+ thymocytes displayed a two-fold increase in proliferation rate, as determined by BrdU incorporation in vivo. These results reinforce the importance of TGF- as an immune regulator critical for T cell function.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Tiedt, H. Hao-Shen, M. A. Sobas, R. Looser, S. Dirnhofer, J. Schwaller, and R. C. Skoda
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Blood,
April 15, 2008;
111(8):
3931 - 3940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pan, T. Schomber, C. P. Kalberer, L. M. Terracciano, K. Hafen, W. Krenger, H. Hao-Shen, C. Deng, and R. C. Skoda
Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice
Blood,
October 15, 2007;
110(8):
3049 - 3055.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|